PAX9 Antikörper
-
- Target Alle PAX9 Antikörper anzeigen
- PAX9 (Paired Box 9 (PAX9))
-
Reaktivität
- Human
-
Wirt
- Ratte
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser PAX9 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC)
- Aufreinigung
- Protein G Chromatography
- Immunogen
- This PAX9 antibody was raised against a recombinant protein corresponding to amino acids to 263-342 of mouse PAX9 protein.
- Klon
- 7C2
- Isotyp
- IgG1
- Top Product
- Discover our top product PAX9 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 1 μg/μL
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
-
Avoid repeated freeze/thaw cycles and keep on ice when not in storage.
- Lagerung
- -80 °C
- Informationen zur Lagerung
- Antibodies in solution can be stored at -80 °C for 2 years.
- Haltbarkeit
- 6 months
-
-
Reduction of Pax9 gene dosage in an allelic series of mouse mutants causes hypodontia and oligodontia." in: Human molecular genetics, Vol. 14, Issue 23, pp. 3605-17, (2005) (PubMed).
: "Progressive loss of PAX9 expression correlates with increasing malignancy of dysplastic and cancerous epithelium of the human oesophagus." in: The Journal of pathology, Vol. 197, Issue 3, pp. 293-7, (2002) (PubMed).
: "
-
Reduction of Pax9 gene dosage in an allelic series of mouse mutants causes hypodontia and oligodontia." in: Human molecular genetics, Vol. 14, Issue 23, pp. 3605-17, (2005) (PubMed).
-
- Target
- PAX9 (Paired Box 9 (PAX9))
- Andere Bezeichnung
- PAX9 (PAX9 Produkte)
- Molekulargewicht
- 38 kDa
- Gen-ID
- 5083
-